Fig. 3.
Engraftment of T-cell–depleted C57BL/6 marrow in B6-Ly5a recipients treated with 100 μg of 30F11 antibody labeled with 0.1 to 1.0 mCi 131I. Proportion of granulocytes (A), B cells (B), and T cells (C) of donor origin (mean ± SD) 3 months after transplantation.